Heading into the third year of the pandemic, virtual care has become more ubiquitous than ever before, and health plans are responding with virtual first health plans that can improve access to care. UnitedHealthcare's Karen Silgen joins the podcast to discuss the rise of virtual care and the recent launch of NavigateNOW.

Hospitals and health systems are increasingly seeking partnerships that can help them improve administrative capabilities and drive strategic growth. Optum Insight's Nick Howell explains why these partnerships can be an alternative to mergers and acquisitions, and how Optum is developing a new industry model.

Biosimilar drugs have the potential to make a significant impact on prescription drug costs. Optum Rx's Savitha Vivian joins the Weekly Dose podcast to discuss the pipeline of biologic drugs and the impact they could have on access and affordability.

A new partnership between Sesame Workshop and UnitedHealthcare aims to build resiliency in children to help them navigate the COVID-19 pandemic.

How has America's health changed during the COVID-19 pandemic? Dr. Rhonda Randall, Chief Medical Officer of UnitedHealthcare E&I, speaks with host Ira Apfel and offers some perspective, using the 2021 America's Health Rankings Annual Report.

Optum's Faiz Ahmad explains the rise of Direct-to-Consumer health care -- and its impact on the industry -- to host Ira Apfel.

In this episode, Weekly Dose Podcast host Ira Apfel looks back at the big health care stories of 2021 and looks ahead to the trending storylines of 2022.

Joy Fitzgerald, Chief Diversity, Equity & Inclusion Officer for UnitedHealth Group, shares her perspective on the evolution of DE&I and what it means to UnitedHealth Group.

The No Surprises Act was passed by Congress to protect consumers from surprise medical bills, which come unexpectedly and often with high price tags. What's really in the legislation? And how will it affect patients, hospitals and insurers? Lisa McDonnel of UnitedHealthcare and Michael Wentzien of Naviguard visited the Weekly Dose to explain.

This week, Dr. Jill Hagenkord visits the Weekly Dose Podcast to discuss genomics -- is it finally ready to fulfill its promise?